Figure 1From: Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanomaSchedule of treatment regimen and blood samples for safety and efficacy endpoints evaluation. T: time point expressed as days or months (m). Pre: pre-treatment time point.Back to article page